Between fundamental and preclinical research in cancerology: evaluation of new CDK8/19 inhibitors

dc.contributor.author	Iris, Moraïtis
dc.date.accessioned	2022-11-29T08:50:58Z
dc.date.available	2022-11-29T08:50:58Z
dc.date.issued	2020
dc.identifier.uri	http://hdl.handle.net/10832/3154
dc.description.abstract	This thesis is a revised and reshaped versionof the French version “Entre recherche fondamentale et préclinique en cancérologie : évaluation de nouveaux inhibiteurs de CDK8/19”. Theprevious thesis was presented and publicly supported on October 6th, 2016in the Faculty of Pharmacy of Nantes in France.	en_US
dc.language.iso	en	en_US
dc.title	Between fundamental and preclinical research in cancerology: evaluation of new CDK8/19 inhibitors	en_US
dc.type	Thesis	en_US